Gilead Sciences Announces First Quarter 2025 Financial Results

Product Sales Excluding Veklury Increased 4% Year-Over-Year to $6.3 billion Biktarvy Sales Increased 7% Year-Over-Year to $3.1 billion FOSTER CITY, Calif.–(BUSINESS WIRE)–#Earnings–Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2025 results of operations. “Gilead had a strong start to the year driven by excellent commercial and clinical execution along with disciplined expense management,” … [Read more…]

Ametros Strengthens Leadership Team with Two Strategic Hires: Mark Long as SVP of Regulatory Affairs and Amanda Smith as VP of Revenue Operations

WILMINGTON, Mass.–(BUSINESS WIRE)–Ametros, the industry leader in professional administration, is pleased to announce two significant additions to its leadership team. Mark Long has joined as Senior Vice President of Regulatory Affairs, and Amanda Smith has been named Vice President of Revenue Operations. These appointments underscore Ametros’ continued growth and commitment to delivering industry-leading support to … [Read more…]

Paige and NHS Wales Launch PanCancer Pilot to Triage Cases with AI at Betsi Cadwaladr University Health Board

NEW YORK–(BUSINESS WIRE)–Paige, a leader in next-generation AI technology, together with NHS Wales, has announced the launch of a new pilot project at Betsi Cadwaladr University Health Board (BCUHB). The project will evaluate how Paige’s AI-assisted diagnostic application, Paige PanCancer Detect, can streamline pathology workflows and enhance patient care by triaging routine clinical cases. The … [Read more…]

Modern Health Appoints Alison Borland as Chief People and Strategy Officer

Veteran Benefits and Well-Being Leader Joins Executive Team to Advance Global Mental Health Impact SAN FRANCISCO–(BUSINESS WIRE)–Modern Health, a leading global workplace mental health platform, today announced the appointment of Alison Borland as Chief People and Strategy Officer, effective immediately. A recognized industry thought leader, Borland brings more than two decades of executive experience in … [Read more…]

Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies

In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets As part of the agreement Astex has taken an equity stake in Mosaic CAMBRIDGE, England–(BUSINESS WIRE)–Mosaic Therapeutics, Ltd (‘Mosaic’, or ‘the Company’) … [Read more…]

Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. Net sales: Achieved 1,129 million USD in net sales, up 8.3% year-on-year on a constant currency basis, primarily driven by volume, complemented by favorable mix … [Read more…]

Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting

Positive data from the Phase 2 PROSPECT Study of tirabrutinib in U.S. patients with relapsed or refractory primary central nervous system lymphoma (PCNSL) will be presented in a rapid oral session. Data on the neoadjuvant ONO-4578 (EP4 antagonist) in combination with nivolumab for rectal cancer will be presented in a poster session. OSAKA, Japan–(BUSINESS WIRE)–Ono … [Read more…]

CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform

Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider … [Read more…]

Arizona Biosciences Set Record Highs in Research Funding, Show Increasing Competitiveness

PHOENIX–(BUSINESS WIRE)–#ASU–Arizona continues to outpace the nation in several key bioscience industry and innovation ecosystem metrics, including gains in jobs and academic R&D expenditures. Still, challenges remain in the areas of commercialization and venture capital deal activity. Those are top-line findings in the latest data analysis commissioned by the Flinn Foundation to track the state’s … [Read more…]

ALLTRUEistic, the World’s First Free App for Collective Meditation and Intention, Goes Live

Empowering communities to transform intention into action for a more harmonious world. SCOTTSDALE, Ariz.–(BUSINESS WIRE)–A new app is inviting people around the world to come together in meditation and intention for personal transformation and global impact. Launching today, ALLTRUEistic offers a powerful premise: when we align our thoughts and emotions with a shared purpose, we … [Read more…]